5-Chloro-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidine-3-carbonitrile → N-[2-[[3-cyano-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidin-5-yl]amino]-5-methyl-4-pyridinyl]acetamide

HRID 725

반응식

HRID 725 반응식
CC(=O)Nc1cc(N)ncc1C.N#Cc1cnn2c(NC3CC3)cc(Cl)nc12>CC(C)c1cc(C(C)C)c(-c2ccccc2P(C(C)(C)C)C(C)(C)C)c(C(C)C)c1.CN(C)C=O.O=C(/C=C/c1ccccc1)/C=C/c1ccccc1.O=C(/C=C/c1ccccc1)/C=C/c1ccccc1.O=C(/C=C/c1ccccc1)/C=C/c1ccccc1.O=C([O-])[O-].[Cs+].[Cs+].[Pd].[Pd]>CC(=O)Nc1cc(Nc2cc(NC3CC3)n3ncc(C#N)c3n2)ncc1C

참가 물질

7

반응 조건

온도
90 °C

실험 절차

Ref: _Angew. Chem. Int. Ed._ **2006** , _45_ , 6523-6527 1\. To a microwave tube was added N-(2-amino-5-methylpyridin-4-yl)acetamide (43 mg, 0.26 mmol), 5-chloro-7-(cyclopropylamino)pyrazolo[1,5-a]pyrimidine-3-carbonitrile (85 mg, 0.36 mmol), Cs2CO3 (254 mg, 0.78 mmol), Pd2dba3 (23.84 mg, 0.03 mmol), and di- tert-butyl(2',4',6'-triisopropylbiphenyl-2-yl)phosphine (22.11 mg, 0.05 mmol). The mixture was dissolved in DMF (1 mL) and sealed. The tube was de-gassed and inflated with N2. 2\. The reaction was heated at 90°C in oil-bath for 4 hr. LCMS showed partial formation of product. Heated overnight at 90°C. 3\. The reaction mixture was filtered through celite pad and the filtrate was loaded onto column and run chromotography to purify (10% MeOH in DCM), semi- pure product was obtained and the sample was submitted to analytical group for further purification. 4\. 10 mg pure product was obtained. 1H NMR (400 MHz, DMSO- _d_ 6) d ppm 0.73 (d, _J_ =2.78 Hz, 2 H) 0.85 (d, _J_ =5.05 Hz, 2 H) 2.15 (d, _J_ =12.88 Hz, 7 H) 2.62 (br. s., 1 H) 7.36 (s, 1 H)7.98 (s, 1 H) 8.09 (s, 1 H) 8.35 (s, 1 H) 8.38 (s, 1 H) 9.38 (s, 1 H) 10.11 (s, 1 H)

출처 및 근거

ORD 기록
ord-96460abed19147c3abf8fef3ac794b48
출처 데이터셋
750 AstraZeneca ELN dataset
원본 링크
출처 보기

연결된 노트

불러오는 중…